|
CCDC120 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.088000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.016600E-01 |
| Normal-vs-Stage2 |
8.523600E-01 |
| Normal-vs-Stage3 |
5.665800E-01 |
| Normal-vs-Stage4 |
1.857580E-01 |
| Stage1-vs-Stage2 |
4.059200E-01 |
| Stage1-vs-Stage3 |
5.759200E-01 |
| Stage1-vs-Stage4 |
5.395700E-02 |
| Stage2-vs-Stage3 |
7.786000E-01 |
| Stage2-vs-Stage4 |
2.718400E-01 |
| Stage3-vs-Stage4 |
1.408020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.182570E-01 |
| Normal-vs-AfricanAmerican |
3.915400E-01 |
| Normal-vs-Asian |
6.997800E-01 |
| Caucasian-vs-AfricanAmerican |
5.798600E-01 |
| Caucasian-vs-Asian |
9.879200E-01 |
| AfricanAmerican-vs-Asian |
8.620000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.815800E-01 |
| Normal-vs-Female |
4.422400E-02 |
| Male-vs-Female |
1.737790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.332600E-01 |
| Normal-vs-Extreme_Weight |
3.656400E-01 |
| Normal-vs-Obese |
3.296000E-02 |
| Normal-vs-Extreme_Obese |
7.464600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.874600E-01 |
| Normal_Weight-vs-Obese |
2.912800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.912800E-01 |
| Extreme_Weight-vs-Obese |
1.422760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.542800E-01 |
| Obese-vs-Extreme_Obese |
1.002560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.477860E-02 |
| Normal-vs-Age(41-60Yrs) |
4.536300E-03 |
| Normal-vs-Age(61-80Yrs) |
9.249600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.827400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.827600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.757700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.056100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.999090E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.000400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.238400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.263000E-03 |
| Normal-VS-Type2 PRCC |
4.940800E-01 |
| Normal-VS-KIRP CIMP |
5.172800E-01 |
| Normal-VS-Unclassified PRCC |
1.509580E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.018400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.870600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.903200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.133400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.935900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.936600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.528200E-01 |
| Normal-vs-N1 |
4.086400E-01 |
| Normal-vs-N2 |
3.557800E-01 |
| N0-vs-N1 |
4.496400E-01 |
| N0-vs-N2 |
3.587000E-01 |
| N1-vs-N2 |
4.077400E-01 |
|
|
